Guanglin Xu

发表论文 7 篇 · 总被引 1 次 · h-index 1

代表论文

• Buyanghuanwu decoction (BYHWD) attenuates hepatic fibrosis in CCl4-induced mice by regulating bile acid metabolism through activating PPARα. (2026 · Journal of Ethnopharmacology · 被引 1)
• M464 inhibits activation of NLRP3 inflammasome and inflammatory response in mice (2025 · Scientific Reports · 被引 1)
• Trace sulfaguanidine additives enabling the development of stable Zn anodes for long life zinc-ion batteries. (2026 · Chemical Communications)
• Harnessing the Versatility of SAM‐Dependent Enzymes: From Mechanism to Application (2026 · ChemBioChem)
• Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transduction. (2026 · Molecular Pharmacology)
• SSD: Targeting inflammasome and oxidative stress as a therapeutic strategy in inflammatory diseases. (2026 · Biochimica et Biophysica Acta - General Subjects)